Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
Stopped early
Conditions studied: Crohn's Disease, Ulcerative Colitis
In brief
The primary purpose of this study is to pilot test an instrument that the investigators will develop to assess decision influences on inflammatory bowel disease patients' medication adherence decision-making. This pilot study will use an exploratory, descriptive cross-sectional survey approach to pilot test the instrument and answer the research questions. The main hypothesis is that patients at risk for intentionally modifying their prescribed medication regimen will differ on influences on decision-making, health status, and utilization of the IBD clinic services compared to those who are intentionally adherent and who continue adherence over time.
Key facts
- Study ID
- NCT00968721
- Run by
- Vanderbilt University
- People needed
- 55
- Starts
- 2010-06-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2016-05-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All Vanderbilt University Medical Center IBD patients that are 18 years or older
- Those who volunteered to participate in this online web-based survey study.
You may not qualify if…
- Vanderbilt University Medical Center patients unable to take the survey because they do not have an e-mail address or access to one.
Where it is running
- Inflammatory Bowel Disease Clinic c/o Divison of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, Vanderbilt University — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.